Acorah Software Products - Accounts Production 16.8.310 false true 30 September 2024 25 September 2023 false 1 October 2024 30 September 2025 30 September 2025 15161627 Mrs Celeste Olayinka Mrs Isabelle Ugochukwu Dr. Austin Umeh iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15161627 2024-09-30 15161627 2025-09-30 15161627 2024-10-01 2025-09-30 15161627 frs-core:CurrentFinancialInstruments 2025-09-30 15161627 frs-core:Non-currentFinancialInstruments 2025-09-30 15161627 frs-core:ShareCapital 2025-09-30 15161627 frs-core:RetainedEarningsAccumulatedLosses 2025-09-30 15161627 frs-bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 15161627 frs-bus:AbridgedAccounts 2024-10-01 2025-09-30 15161627 frs-bus:SmallEntities 2024-10-01 2025-09-30 15161627 frs-bus:AuditExempt-NoAccountantsReport 2024-10-01 2025-09-30 15161627 frs-bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 15161627 frs-bus:Director1 2024-10-01 2025-09-30 15161627 frs-bus:Director2 2024-10-01 2025-09-30 15161627 frs-bus:Director3 2024-10-01 2025-09-30 15161627 frs-countries:EnglandWales 2024-10-01 2025-09-30 15161627 2023-09-24 15161627 2024-09-30 15161627 2023-09-25 2024-09-30 15161627 frs-core:CurrentFinancialInstruments 2024-09-30 15161627 frs-core:Non-currentFinancialInstruments 2024-09-30 15161627 frs-core:ShareCapital 2024-09-30 15161627 frs-core:RetainedEarningsAccumulatedLosses 2024-09-30
Registered number: 15161627
Medtech Solutions Global Ltd
Unaudited ABRIDGED Financial Statements
For The Year Ended 30 September 2025
VIBAS Accountants
Contents
Page
Abridged Balance Sheet 1—2
Notes to the Abridged Financial Statements 3
Page 1
Abridged Balance Sheet
Registered number: 15161627
2025 2024
Notes £ £ £ £
CURRENT ASSETS
Debtors 770,691 771,683
Cash at bank and in hand 419 4,978
771,110 776,661
Creditors: Amounts Falling Due Within One Year (17,922 ) (6,118 )
NET CURRENT ASSETS (LIABILITIES) 753,188 770,543
TOTAL ASSETS LESS CURRENT LIABILITIES 753,188 770,543
Creditors: Amounts Falling Due After More Than One Year (19,225 ) (14,500 )
NET ASSETS 733,963 756,043
CAPITAL AND RESERVES
Called up share capital 4 770,001 770,001
Profit and Loss Account (36,038 ) (13,958 )
SHAREHOLDERS' FUNDS 733,963 756,043
Page 1
Page 2
For the year ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
All of the company's members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet for the year end 30 September 2025 in accordance with section 444(2A) of the Companies Act 2006.
On behalf of the board
Mrs Isabelle Ugochukwu
Director
21/04/2026
The notes on page 3 form part of these financial statements.
Page 2
Page 3
Notes to the Abridged Financial Statements
1. General Information
Medtech Solutions Global Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15161627 . The registered office is 86-90 Paul Street, 3rd Floor, London, EC2A 4NE.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 3 (2024: 3)
3 3
4. Share Capital
2025 2024
£ £
Called Up Share Capital not Paid 770,001 770,001
Amount of Allotted, Called Up Share Capital 770,001 770,001
Page 3